RELATED: Hard-hit states skyrocketing demand for COVID-19 antibody drugsThe FDA has stressed that antibody drugs are not a substitute for vaccination, which is the most effective, long-lasting form of virus protection.
Antibody drugs also are expensive to produce and require an IV or injection and health care workers to administer.Late-stage human trials showed that AstraZeneca’s antibody drug reduced the risk of developing symptomatic COVID-19 by 77%.